Brief: Neovacs Announces Start Of Strategic Plan To Relaunch Research

Neovacs SA

13/07/2020 07:32

July 13 (Reuters) - Neovacs SA  ALNEV.PA :
    * ANNOUNCES START OF ITS STRATEGIC PLAN AIMED AT RELAUNCHING
ITS
TWO RESEARCH PROGRAMS, AND ENGAGING IN INVESTMENT ACTIVITY IN
THE BIOTECH OR MEDTECH
    * RESUMED EFFORTS WITH VIEW TO VALIDATION BY EMA ( EUROPEAN
MEDICINES AGENCY ) OF LLDAS CRITERION FOR A PHASE III TRIAL WITH
ITS PRODUCT IFNΑ KINOID
    * OBJECTIVE IS TO LAUNCH A PHASE III STUDY THANKS TO
CO-FINANCING
WITH A PHARMACEUTICAL PARTNER
    * ALSO INITIATED A RESEARCH PROJECT AIMED AT GENERATING
KINOIDS 3
RD GENERATION

Source text for Eikon  ID:nACT64261 
Further company coverage:  ALNEV.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))